pharmaadvancement.com   Monthly E-newsletter - June 2022
 
Cell Therapy Durability Response Summit
 
Newsletter on Pharma advancement
Pharma Advancment news letter subscribe Advertise with us
June - 2022 - Volume 7 I Pharma Advancement E-newsletter
  Pharma Advancement on LinkedIn Pharma Advancement on Facebook
Insights  
Time Congress Acts As Drug Launch Prices Go Up 20% Annually

As many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years: drug prices are significantly higher than in the past.

History Created- Every Patient In Drug Trial Is Cancer-Free
Promising Findings of Drug Mix Targeting Cancers Death Star
ICMR Issues Standards For Drones To Deliver Medical Supplies
Distancing From China Can Lead To India Being World Pharmacy
 
 
Advertise in Our Next Issue - Contact
E: peter@pharmaadvancement.com
W: www.pharmaadvancement.com
COVID-19 News  
FDA Officials Support Moderna, Pfizer COVID-19 Jabs For Kids

Parents may soon be allowed to line up their children for vaccinations after Pfizer and Moderna’s COVID-19 vaccine application for young children progresses through the FDA’s regulatory procedure.

Pfizer Invests $120mn On U.S. COVID-19 Oral Drug Production

COVID-19’s propensity to fuel domestic drug production hasn’t waned two years into the pandemic.Take, for example, Pfizer’s new $120 million investment.

J&J, BMS Arthritis Drugs Cut Mortality In COVID Patients

While the COVID-19 outbreak prompted the development of novel antibody medicines and vaccinations, scientists have discovered that current medications can occasionally aid patients in their fight against the virus.

Popular Events

The Onco Cell Therapy Summit 2022

2022-06-29 - 2022-06-30
Boston
W: https://oncocelltherapy.com/events/octs-usa

Cell Therapy Durability Response Summit 2022
2022-08-22 - 2022-08-23
Massachusetts, USA
W: https://celltherapydurability.com

ACHEMA 2022
2022-08-22 - 2022-08-26
Messe Frankfurt, Germany
W: https://www.achema.de/en/

 
Cell Therapy Durability Response Summit
 

pharmaadvancement.com

     

Editorial Inquiries

Advertising Inquiries